Dr Amin Ardestani A.Ardestani@hull.ac.uk
Senior Lecturer
Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
Ardestani, Amin; Tremblay, Matthew S.; Shen, Weijun; Maedler, Kathrin
Authors
Matthew S. Tremblay
Weijun Shen
Kathrin Maedler
Citation
Ardestani, A., Tremblay, M. S., Shen, W., & Maedler, K. (2019). Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes. Cell Death Discovery, 5(1), Article 149. https://doi.org/10.1038/s41420-019-0232-0
Journal Article Type | Note |
---|---|
Acceptance Date | Nov 19, 2019 |
Online Publication Date | Dec 5, 2019 |
Publication Date | Dec 1, 2019 |
Deposit Date | Jan 4, 2024 |
Publicly Available Date | Jan 5, 2024 |
Journal | Cell Death Discovery |
Electronic ISSN | 2058-7716 |
Publisher | Springer Nature [academic journals on nature.com] |
Peer Reviewed | Peer Reviewed |
Volume | 5 |
Issue | 1 |
Article Number | 149 |
DOI | https://doi.org/10.1038/s41420-019-0232-0 |
Keywords | Type 1 diabetes; Type 2 diabetes |
Public URL | https://hull-repository.worktribe.com/output/4461595 |
Files
Published article
(449 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0
Copyright Statement
© The Author(s) 2019.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
You might also like
Abnormal acinar–β-cell crosstalk in type 2 diabetes
(2023)
Journal Article